Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES
|
|
|
Industry Insights |
|
|
Will ChatGPT change the pharmaceutical drives business strategy and forecasting?
What does ChatGPT mean for Business Strategy & Forecasting in Pharmaceuticals?
|
|
|
|
|
|
|
|
|
|
New UK Biotech Centres To Boost Cell And Gene Therapies
To overcome dearth when it comes to cell therapy manufacturing in UK, National Health Service Blood and Transplant has come up with new production facility.
|
|
|
|
|
|
Double The Drugs For Price Negotiation, Says President Biden
With 20 drugs initially to 300 drugs by 2033, President Joe Biden is wanting Medicare to negotiate drug prices as per his budget proposal for the next year.
|
|
|
|
|
|
|
|
|
|
Australian University to Head $15m Mitochondrial Clinical Trial
Clinical trial of Mitochondrial donation with $15 million happens to be first of its kind in Australia and second across the world to eradicate the disease.
|
|
|
|
|
|
|
Press Releases |
|
|
Lonza Upgrades Powder Characterization Capabilities
Lonza recently announced a significant enhancement to its powder characterization capabilities at its Small Molecules site in Tampa, Florida, US.
|
|
|
|
|
|
|
|
|
|
Digital solutions for liquid pharmaceutical processing from Syntegon
At this year’s interpack, Syntegon will provide insights into the future of liquid pharmaceutical processing.
|
|
|
|
|
|
Vetter strengthens worldwide commitment to sustainable business practices
Ravensburg, March 8th, 2023 – Vetter has recently become a participant of the UN Global Compact Network (UN GC).
|
|
|
|
|
|
|
|
|
|
Charles River Launches Helper Plasmid to Streamline Adeno-Associated Viral Vector Manufacturing
Charles River Laboratories announced the launch of its off-the-shelf pHelper offering, which is designed to secure supply and streamline adeno-associated virus (AAV)-based gene therapy programs from early discovery through commercial manufacturing.
|
|
|
|
|
|